Dynavax Technologies | 전 세금 이익



Pre Tax Profit 변화 날짜
AbbVie USD 4.81B 1.54B 2024-12
Adma Biologics USD 34.71M 2.04M 2024-12
Amgen USD 3.38B 111M 2024-12
AstraZeneca USD 3.4B 1.74B 2025-03
Biogen USD 572.2M 118.5M 2024-12
BioMarin Pharmaceutical USD 169.64M 35.2M 2024-12
Bristol-Myers Squibb USD 2.97B 1.29B 2025-03
Dynavax Technologies USD -97875000 105.5M 2025-03
Gilead Sciences USD 2.96B 112M 2024-12
Glaxosmithkline USD 1.66B 1.78B 2024-12
Merck USD 5.22B 114M 2024-12
Neurocrine Biosciences USD 162.6M 27.7M 2024-12
Novartis USD 4.66B 269M 2024-12
Pfizer USD 4.44B 2.36B 2024-12
Regeneron Pharmaceuticals USD 905M 53.1M 2025-03
Roche Holding CHF 1.78B 2.33B 2024-12
Sarepta Therapeutics USD -383518000 555.26M 2025-03
TG Therapeutics USD 25.45M 21.18M 2024-12
Vertex Pharmaceuticals USD 1.32B 109.7M 2024-12



Dynavax Technologies 전 세금 이익 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - May 2025.